USAID SUSTAINABLE FINANCING FOR HIV
National Consultant
To conduct systematic review on efficacy and cost effectiveness of TLD and support VAAC
in the process of preparing dossier to include Tenofovir/Lamivudine/Dolutegravir (TLD)
into Social Health Insurance drug list
I. Background of the assignment
The 2-year USAID Sustainable Financing for HIV Activity provides technical assistance to the Government of Vietnam (GVN) from October 1, 2018 to September 30, 2020. It builds on support provided to the GVN since 2014 through the Health Finance and Governance (HFG) project.
USAID Sustainable Financing for HIV Activity will provide technical assistance to GVN to complete the transition to a domestically-funded HIV program able to exceed the 9090-90 targets – 90% of people living with HIV (PLHIV) tested, 90% on anti-retroviral treatment (ART), and 90% virally suppressed – thereby achieving epidemic control. The project will provide specialized expertise to deliver targeted, innovative, evidence-based, and results-driven technical assistance designed to: 1) increase in-country capacity to self-finance and sustain HIV control efforts; and 2) strengthen government capacity on ARV supply planning, quantification, bidding, and procurement financing through the SHI fund.
In Vietnam, optimization of current antiretroviral drug regimens is a critical component in supporting country efforts to achieve the 90/90/90 treatment targets and epidemic control. Following 2018 WHO guidance for HIV care and treatment, the Tenofovir/Lamivudine/Dolutegravir (TLD) fixed dose combination has become the preferred first-line ART option for patients. HIV patients started to receive the first SHI-covered ARVs since March, 2019. The MOH issued a TLD Market Authorization in October 2019. VAAC is planning to include TLD in the SHI drug list to ensure that patients will receive SHI-covered TLD in 2022.
USAID Sustainable Financing for HIV seeks to hire National Consultant to conduct systematic review on efficacy and cost effectiveness of TLD and support VAAC in the process of preparing dossier to include TLD into Social Health Insurance drug list for HIV response in Vietnam.
II. Tasks
III. Qualification requirements
Note: This position is based in Hanoi, Vietnam.
To apply, please send your application documents to Ms Thanh Hien with the following email:
Deadline: March 13, 2020
Only short-listed candidates will be contacted for interviews.